Zoekresultaten - 2 results
Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe.
therapy were lung transplantation, cystic fibrosis-related diabetes (CFRD), moderate or severe lung disease and azithromycin use (often considered a surrogate marker for infection and poorer lung function). ...
Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study.
with older age, non-white race, underweight body mass index, and CF-related diabetes. Prescription of highly effective CFTR modulator therapies was associated with a significantly reduced odds of being ...